in Wiley Online Library (wileyonlinelibrary.com).Synthesis of unreported hitherto N,N 0 -([1,1 0 -biphenyl]-4,4 0 -diyl)bis(2-cyanoacetamide) as a precursor to synthesize bis-chromenes, bis-thiazole derivatives, and bis-pyridizines. The structures of the newly synthesized compounds were established by their elemental analyses and spectral data. Some of the newly synthesized compounds were tested for in vitro activity against hepatocellular carcinoma, human breast cancer, and human cervical carcinoma cell lines compared with the employed standard antitumor drug (doxorubicin), and the results revealed that the starting N,N 0 -([1,1 0 -biphenyl]-4,4 0 -diyl)bis(2-cyanoacetamide) is more potent activity than doxorubicin against hepatocellular carcinoma and human cervical carcinoma.